Health Condition 1: E780- Pure hypercholesterolemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Clinically diagnosed patients of dyslipidemia. 2.Primary inclusion window: Patients with mild to severe dyslipidemia (borderline to high) with Total Cholesterol level 200 mg per dl or more. 3.Patients who are willing and able to provide written informed consent. 4.Patients who are able to understand and follow the study protocol for the entire duration of the study.
Exclusion criteria
Exclusion criteria: 1.Presence of secondary dyslipidemia. 2. Patients with diabetes mellitus or any other endocrinal disorders, cardiovascular disease, uncontrolled hypertension, renal insufficiency, or any other chronic illness and patient with terminal medical conditions such as AIDS, cancer etc. 3.Pregnant and lactating women. 4. Patient taking any medication that might affect serum lipids. (thyroid or steroid hormones, beta blocker, prednisolone or diuretics etc). 5. Patient who refuse written consent form for the study. 6.Patients not willing to report for follow up. 7.Exclusion by patient history & investigations if needed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the efficacy and safety of the proposed compound unani formulation in the treatment of dyslipidemia by assessing changes in lipid profile parameters on scientific parameters.Timepoint: 1.To evaluate efficacy: Assessment of lipid profile on baseline and 45th day. 2.To evaluate safety: Haemogram, LFT, KFT at baseline and 45th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life.Timepoint: Assessment of quality of life index at baseline and after 45th day. | — |
Countries
India
Contacts
Ayurvedic and Unani Tibbia College and Hospital